Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Talima Therapeutics

75 Shoreway Road #C
San Carlos, CA 94070
650 331 7246
Website Company Summary Management Team

Finance: Paul Denton (1/04)

Outside board: (May no longer be on the board) David Henkel-Wallace (Talima Therapeutics Former CEO) Jane E. Shaw (Aerogen Former CEO) Philip M. Young (U.S. Venture Partners Partner) Robert L. Roe (Corcept Therapeutics President) James N. Woody (Latterell Venture Partners Partner) Fred Dotzler (De Novo Ventures Director)

Business description: Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy, we design customized drug-delivery systems that optimize the local therapeutic performance and reduce the undesired systemic side effects enabling us to address unmet needs or underserved markets. We foster a collaborative environment and strive for excellence internally and with our partners. Our lead product is currently in Phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the nails and we are in the process of planning its pivotal trials.

Rounds: 2
Recent Fundings: May 2007   Jun 2005
Capital raised: 21.0M
Last Round: 19.0M
Ownership: Private  

Last Tweets


Last Mentions

Record updated: May 2009
Sector: Medical
Year Founded: 2005
Rounds: 2
Recent Fundings: May 2007   Jun 2005
Capital Raised: 21.0M
Last Round: 19.0M
Ownership: Private